Large scale high urgency trials require continuous oversight, clear data review, and rapid turnaround times. In this resource, you will learn how a global pharmaceutical sponsor partnered with MMS to provide full statistical and programming support for an Independent Data Monitoring Committee overseeing a two part study in patients with severe COVID related disease.

Designed for clinical operations leaders, biometrics directors, and trial oversight teams, this overview highlights how MMS aligned with regulatory expectations, built secure unblinded environments, and delivered critical safety and efficacy outputs within strict timelines. With multiple interim analyses and fast moving study conditions, the role of a reliable IDMC support partner became essential.

By exploring this content, you will gain insight into the operational rigor, communication clarity, and methodological expertise needed to maintain trial integrity, ensure participant safety, and guide evidence driven decision making under pressure.

Key Benefits / What You Will Learn:

• See how MMS established secure firewalled environments for unblinded data and confidential communications.
• Learn how rapid turnaround workflows enabled IDMC meetings on accelerated timelines.
• Understand how expert statisticians supported both open and closed sessions and explained complex Bayesian and frequentist stopping rules.
• Discover how consistent delivery and clear outputs helped the sponsor maintain safety oversight and reach confident decisions throughout the trial.

Developed by MMS biostatistics experts with extensive experience supporting IDMCs and Independent Statistics and Programming Teams across global clinical programs.